About Sangel Capital
Sangel Capital is a Financial Services company based in Shenzhen (China). A venture capital firm focused on life sciences investments. It operates on a Commission-Based model. Sangel Capital offers products and services including Venture Capital Investment. Its focus areas include Finance, Venture Capital and Biotechnology Investment.
Company details
Shenzhen Sangel Venture Capital Co., Ltd. is recognized as one of the earliest professional biomedical venture capital firms in China with global operations. Investments are directed towards the life sciences sector, targeting innovative growth companies with significant capital value and commercial potential. A leading position is held in the biomedical investment industry through professional expertise and extensive project resources. Offices are maintained in Shenzhen, Beijing, Suzhou, and Chicago, where a team of industry experts, scientists, and investors manages a series of RMB and USD funds. Benchmark companies in niche sectors are nurtured through strategic investments.
- Headquarters Shenzhen, China
- SectorsFinancial Services
- Email••••••••
- Phone•••• ••••
- Website sangelvc.com
Products & Services of Sangel Capital
Sangel Capital offers a comprehensive portfolio of products and services, including Venture Capital Investment.
Investments are made in life sciences innovation companies.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sangel Capital
Sangel Capital is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Shenzhen Sangel Venture Capital Co., Ltd. is recognized as one of the earliest professional biomedical venture capital firms in China with global operations. Investments are directed towards the life sciences sector, targeting innovative growth companies with significant capital value and commercial potential. A leading position is held in the biomedical investment industry through professional expertise and extensive project resources. Offices are maintained in Shenzhen, Beijing, Suzhou, and Chicago, where a team of industry experts, scientists, and investors manages a series of RMB and USD funds. Benchmark companies in niche sectors are nurtured through strategic investments.
Sangel Capital offers Venture Capital Investment.